High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level

被引:0
作者
Chunsen Xu
Mutsuko Yamamoto-Ibusuki
Yutaka Yamamoto
Satoko Yamamoto
Saori Fujiwara
Keiichi Murakami
Yasuhiro Okumura
Lisa Yamaguchi
Yoshitaka Fujiki
Hirotaka Iwase
机构
[1] Kumamoto University,Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences
[2] Fujian Medical University,Department of Breast Surgery, Affiliated Union Hospital
来源
Breast Cancer | 2014年 / 21卷
关键词
Survivin; Breast cancer; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:482 / 490
页数:8
相关论文
共 193 条
[11]  
Berns EM(2008)New wirings in the survivin networks Oncogene 8 2708-2710
[12]  
Klijn JG(2009)Survivin as a global target of intrinsic tumor suppression networks Cell Cycle 10 35-46
[13]  
Olopade OI(2011)Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin Mol Cancer 201 225-236
[14]  
Grushko TA(2003)Lack of prognostic significance of survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag-1, bax-alpha and MRP-1 mRNAs in breast cancer Cancer Lett 100 161-167
[15]  
Nanda R(2006)Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survival Breast Cancer Res Treat 88 1077-1083
[16]  
Huo D(2003)Prognostic importance of survivin in breast cancer Br J Cancer 50 1986-1993
[17]  
Ross JS(2004)Survivin is an independent prognostic marker for risk stratification of breast cancer patients Clin Chem 16 1569-1583
[18]  
Slodkowska EA(2011)Total survivin and acetylated survivin correlate with distinct molecular subtypes of breast cancer Hum Pathol 18 vi63-5
[19]  
Symmans WF(2005)Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005 Ann Oncol 18 1133-1144
[20]  
Pusztai L(2007)Adjuvant strategies in breast cancer: new prospectives, questions and reflections at the end of 2007 St Gallen International Expert Consensus Conference Ann Oncol 110 465-475